buprenorphine 2mg tablet price in pakistan

buprenorphine 2mg tablet price in pakistan is a specialized anti-cancer medicine used in the treatment of HER2-positive breast cancer. It contains the active ingredient ado-trastuzumab emtansine, a targeted therapy that combines monoclonal antibody treatment with chemotherapy. Because of its advanced formulation and effectiveness, Kadcyla is considered a high-cost oncology drug worldwide, including in Pakistan.

 

 

 

buprenorphine 2mg tablet price in pakistan

 

 

 

buprenorphine 2mg tablet price in pakistan injection in Pakistan varies depending on the supplier, availability, and import conditions. On average, the cost typically ranges between PKR 138,450 to PKR 354,535 per vial.

 

 

 

Some online pharmacy listings and medical stores report a standard price of around PKR 138,450, which is commonly seen for a single 160mg vial supplied by Roche Pakistan. However, other platforms show significantly higher prices, reaching PKR 300,000+, especially when imported or sold through specialized oncology channels.

 

 

 

The price difference is influenced by factors such as:

 

 

 

 

 

      • Import duties and taxes

 

 

 

      • Currency exchange fluctuations

 

 

 

      • Availability and supply chain constraints

 

 

 

      • Hospital or pharmacy pricing policies

 

 

 

 

 

Due to these variables, patients may notice price fluctuations over time or across different cities in Pakistan.

 

 

 

Why Kadcyla Is Expensive

 

 

 

Kadcyla is not a conventional chemotherapy drug. It is a targeted therapy designed specifically for cancer cells that overexpress the HER2 protein. The medicine works by attaching to cancer cells and delivering chemotherapy directly into them, reducing damage to healthy cells.

 

 

 

This advanced mechanism makes Kadcyla highly effective but also costly. The drug is manufactured using complex biotechnology processes, which significantly increases production expenses. Additionally, it is produced by a global pharmaceutical company and often imported into Pakistan, further raising its price.

 

 

 

International Price Comparison

 

 

 

Globally, Kadcyla is also considered expensive. For example, in the United States, a 160mg vial can cost around $6,400 or more, depending on the supplier. This shows that the high price in Pakistan is consistent with its global market value, though local affordability remains a challenge.

 

 

 

Availability in Pakistan

 

 

 

Kadcyla 160mg injection is available in major hospitals, oncology centers, and selected online pharmacies in Pakistan. However, it is strictly a prescription-only medicine and must be administered by qualified healthcare professionals.

 

 

 

Because it requires cold storage and careful handling, it is usually supplied through specialized medical channels rather than regular pharmacies. Delivery may also involve cold-chain logistics to maintain its effectiveness.

 

 

 

Factors Affecting Patient Cost

 

 

 

While the listed price may seem fixed, the actual amount a patient pays can vary. Some influencing factors include:

 

 

 

 

 

      • Hospital treatment packages

 

 

 

      • Insurance coverage (if available)

 

 

 

      • Government or charity assistance programs

 

 

 

      • Bulk purchase or institutional discounts

 

 

 

 

 

In certain cases, patients may receive financial support through cancer welfare organizations or hospital-based subsidy programs, which can significantly reduce the cost burden.

 

 

 

Usage and Treatment Duration

 

 

 

Kadcyla is typically administered through intravenous infusion under medical supervision. The number of doses required depends on the patient’s condition, cancer stage, and response to treatment.

 

 

 

Since treatment may involve multiple cycles, the overall cost can become substantial, making affordability a major concern for many patients in Pakistan.

 

 

 

Conclusion

 

 

 

Buprenorphine 2mg tablet price in pakistan is a highly effective but expensive treatment for HER2-positive breast cancer in Pakistan. With prices generally ranging from PKR 138,450 to over PKR 300,000 per vial, it remains one of the costlier oncology medications available. The high price reflects its advanced targeted therapy mechanism and complex manufacturing process.